Singapore markets close in 1 hour 20 minutes

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
19.8200.000 (0.00%)
As of 3:21PM HKT. Market open.
Currency in HKD

Valuation measures

Market cap (intra-day) 556.18B
Enterprise value 324.1B
Trailing P/E 9.04
Forward P/E 17.23
PEG Ratio (5 yr expected) 11.19
Price/sales (ttm)0.83
Price/book (mrq)1.16
Enterprise value/revenue 30.36
Enterprise value/EBITDA 75.91

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 34.32%
S&P500 52-week change 332.94%
52-week high 326.200
52-week low 318.200
50-day moving average 320.532
200-day moving average 321.088

Share statistics

Avg vol (3-month) 31.71M
Avg vol (10-day) 3848.81k
Shares outstanding 5219.9M
Implied shares outstanding 61.63B
Float 8759.26M
% held by insiders 10.00%
% held by institutions 128.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.65
Forward annual dividend yield 43.30%
Trailing annual dividend rate 30.54
Trailing annual dividend yield 32.71%
5-year average dividend yield 4N/A
Payout ratio 450.25%
Dividend date 3N/A
Ex-dividend date 421 Jun 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 5.43%
Operating margin (ttm)5.54%

Management effectiveness

Return on assets (ttm)3.96%
Return on equity (ttm)13.56%

Income statement

Revenue (ttm)67.33B
Revenue per share (ttm)41.42
Quarterly revenue growth (yoy)19.30%
Gross profit (ttm)10.39B
EBITDA 4.08B
Net income avi to common (ttm)3.65B
Diluted EPS (ttm)2.191
Quarterly earnings growth (yoy)50.70%

Balance sheet

Total cash (mrq)22.11B
Total cash per share (mrq)13.6
Total debt (mrq)11.8B
Total debt/equity (mrq)39.37
Current ratio (mrq)1.66
Book value per share (mrq)17.08

Cash flow statement

Operating cash flow (ttm)5.17B
Levered free cash flow (ttm)635.88M